Deir ez-Zor, Syria – At least 16 cases of AIDS were reported in the ranks of the Islamic State radical group (IS/ISIS) in al-Mayadeen city in the eastern Syrian province of Deir ez-Zor, medical sources reported on Tuesday.
Medical sources in the national hospital of al-Mayadeen told ARA News that more than 16 IS militants are currently held in a quarantine center after being tested positive with AIDS.
“Most of those infected are foreign militants who had sexual intercourses with two Moroccan women. The women passed on the disease to the militants before their infection was revealed. We were ordered by the group’s local leadership to transfer the infected militants to a quarantine center in the city,” a Syrian doctor in al-Mayadeen told ARA News on the condition of anonymity.
The source added that the two Moroccan women escaped to Turkey “for fear of execution by the IS”.
A state of panic hit the group’s ranks in Deir ez-Zor after the cases of AIDS were uncovered. The IS leadership issued a decision through its Sharia Commission to run tests for AIDS on its members in Deir ez-Zor in order to avoid further spread of the disease.
“IS leadership is planning to assign suicide attacks for its militants who are tested positive with AIDS,” a civil rights activist in al-Mayadeen reported.
This comes three months after reports on similar cases among IS militants in the city of Shaddadi in Hasakah province, where an Indonesian fighter of IS passed AIDS on to his Yezidi sex slave. The same slave has been later sold to other members of the radical group, causing a state of panic in the ranks of IS in Shaddadi.
The infected militant has also donated blood at an IS-held hospital in Shaddadi earlier in May, before being tested positive with AIDS, which raised the group’s concerns about possible infection of dozens other militants.
The radical group executed the Indonesian militant and a Saudi doctor who revealed the information on the spread of AIDS in Shaddadi city last June.
Reporting by: Sarbaz Yousef
Source: ARA News
For the latest news follow us on Twitter
Join our Weekly Newsletter